35
Participants
Start Date
August 29, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2028
Mycophenolate Mofetil
"The participant will receive 500 mg to 1000 mg twice daily of mycophenolate mofetil administered orally for 96 weeks.~The dose scheduling will be as follow:~Weeks 1 and 2: 500 mg twice a day Weeks 3 and 4: 750 mg twice a day Weeks 5 to 96: 1000 mg twice a day"
Placebo
"The participant will receive 500 mg to 1000 mg twice daily of placebo administered orally for 96 weeks.~The dose scheduling will be as follow:~Weeks 1 and 2: 500 mg twice a day Weeks 3 and 4: 750 mg twice a day Weeks 5 to 96: 1000 mg twice a day"
RECRUITING
Centre hospitalier de l'Université de Montréal (CHUM), Montreal
NOT_YET_RECRUITING
Jewish General Hospital - CIUSSS-COMTL, Montreal
NOT_YET_RECRUITING
Institut Universitaire de Cardiologie et Pneumologie de Québec, Québec
McGill University
OTHER
University of Calgary
OTHER
Jewish General Hospital
OTHER
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Sclérodermie Québec
UNKNOWN
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
OTHER
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER